Caz Investments Lp decreased its stake in Johnson And Johnson Com (JNJ) by 49.5% based on its latest 2017Q3 regulatory filing with the SEC. Caz Investments Lp sold 7,430 shares as the company’s stock rose 6.85% with the market. The institutional investor held 7,580 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $985,000, down from 15,010 at the end of the previous reported quarter. Caz Investments Lp who had been investing in Johnson And Johnson Com for a number of months, seems to be less bullish one the $394.54B market cap company. The stock increased 0.75% or $1.1 during the last trading session, reaching $146.86. About 8.80M shares traded or 58.28% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 17, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.
Thomas White International Ltd decreased its stake in Humana Inc (HUM) by 59.56% based on its latest 2017Q3 regulatory filing with the SEC. Thomas White International Ltd sold 2,541 shares as the company’s stock rose 11.38% with the market. The institutional investor held 1,725 shares of the medical specialities company at the end of 2017Q3, valued at $420,000, down from 4,266 at the end of the previous reported quarter. Thomas White International Ltd who had been investing in Humana Inc for a number of months, seems to be less bullish one the $37.71 billion market cap company. The stock increased 0.80% or $2.15 during the last trading session, reaching $270.17. About 1.77 million shares traded or 43.15% up from the average. Humana Inc. (NYSE:HUM) has risen 35.38% since January 17, 2017 and is uptrending. It has outperformed by 18.68% the S&P500.
Investors sentiment increased to 1.21 in Q3 2017. Its up 0.01, from 1.2 in 2017Q2. It is positive, as 44 investors sold HUM shares while 184 reduced holdings. 76 funds opened positions while 201 raised stakes. 131.39 million shares or 2.57% less from 134.86 million shares in 2017Q2 were reported. Winslow Evans & Crocker Inc holds 0.08% or 944 shares in its portfolio. Jefferies Gru Lc has invested 0.06% in Humana Inc. (NYSE:HUM). Perigon Wealth Mngmt Limited Company reported 50 shares or 0% of all its holdings. Renaissance Ltd Liability stated it has 1.05% in Humana Inc. (NYSE:HUM). Peak6 Investments Lp accumulated 36,316 shares. Asset Management One Limited holds 0.13% in Humana Inc. (NYSE:HUM) or 230,709 shares. Virginia Retirement Et Al owns 10,300 shares. Hanson Doremus Inv Mngmt, Vermont-based fund reported 2,250 shares. Euclidean Technologies Mngmt Ltd Liability reported 7,860 shares. Bluecrest Capital Management has 6,710 shares. Segall Bryant & Hamill Limited Com reported 981 shares. Cullen Frost Bankers has invested 0.01% in Humana Inc. (NYSE:HUM). Koshinski Asset accumulated 0.11% or 1,335 shares. Gabelli Funds Limited Liability Company holds 55,200 shares or 0.08% of its portfolio. Creative Planning holds 0.01% of its portfolio in Humana Inc. (NYSE:HUM) for 4,887 shares.
Since August 10, 2017, it had 0 buys, and 7 selling transactions for $16.22 million activity. 3,071 shares were sold by Fleming William Kevin, worth $770,760 on Wednesday, August 23. The insider BILNEY JODY L sold $1.75 million. Another trade for 7,803 shares valued at $2.01M was sold by Huval Timothy S.. Shares for $2.53 million were sold by Bierbower Elizabeth D on Friday, September 1. 22,935 shares were sold by Christopher M Todoroff, worth $5.79M on Thursday, August 10.
Among 23 analysts covering Humana (NYSE:HUM), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Humana had 67 analyst reports since July 30, 2015 according to SRatingsIntel. The company was downgraded on Monday, October 9 by JP Morgan. Cantor Fitzgerald maintained it with “Hold” rating and $230.0 target in Wednesday, November 8 report. Cowen & Co maintained the shares of HUM in report on Thursday, July 13 with “Buy” rating. The stock of Humana Inc. (NYSE:HUM) has “Hold” rating given on Monday, October 9 by J.P. Morgan. On Wednesday, September 20 the stock rating was maintained by Cowen & Co with “Buy”. The firm has “Overweight” rating by Morgan Stanley given on Thursday, August 17. The firm has “Sector Perform” rating by RBC Capital Markets given on Thursday, October 13. JP Morgan initiated the shares of HUM in report on Wednesday, September 16 with “Overweight” rating. As per Wednesday, December 7, the company rating was downgraded by Cantor Fitzgerald. The firm earned “Outperform” rating on Thursday, March 30 by Oppenheimer.
Thomas White International Ltd, which manages about $2.28B and $572.21 million US Long portfolio, upped its stake in Regions Financial Corp New (NYSE:RF) by 42,645 shares to 104,853 shares, valued at $1.60M in 2017Q3, according to the filing. It also increased its holding in Wns Holdings Ltd Adr (NYSE:WNS) by 24,591 shares in the quarter, for a total of 94,510 shares, and has risen its stake in Shire Plc Adr (NASDAQ:SHPG).
Analysts await Humana Inc. (NYSE:HUM) to report earnings on February, 14. They expect $2.00 EPS, down 4.31% or $0.09 from last year’s $2.09 per share. HUM’s profit will be $279.15M for 33.77 P/E if the $2.00 EPS becomes a reality. After $3.39 actual EPS reported by Humana Inc. for the previous quarter, Wall Street now forecasts -41.00% negative EPS growth.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 85 analyst reports since August 7, 2015 according to SRatingsIntel. Barclays Capital maintained the shares of JNJ in report on Wednesday, October 18 with “Equal-Weight” rating. Argus Research upgraded it to “Buy” rating and $145 target in Wednesday, July 20 report. JP Morgan downgraded the stock to “Neutral” rating in Tuesday, January 2 report. The firm has “Hold” rating given on Monday, September 25 by Citigroup. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Wells Fargo on Monday, October 9. On Wednesday, July 19 the stock rating was maintained by UBS with “Buy”. The firm has “Neutral” rating given on Wednesday, April 20 by Goldman Sachs. The firm has “Buy” rating by RBC Capital Markets given on Sunday, August 27. The stock has “Buy” rating by BMO Capital Markets on Tuesday, July 18. The firm has “Buy” rating by Cowen & Co given on Thursday, August 24.
Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It is flat, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Foothills Asset Limited stated it has 1.35% of its portfolio in Johnson & Johnson (NYSE:JNJ). Ckw Financial Group holds 0.02% or 664 shares in its portfolio. Moreno Evelyn V owns 56,859 shares for 2.21% of their portfolio. Aldebaran Fin Inc has invested 3.29% of its portfolio in Johnson & Johnson (NYSE:JNJ). Amer Asset Mgmt accumulated 7,633 shares or 0.61% of the stock. Convergence Ptnrs Ltd Com invested in 4,596 shares or 0.08% of the stock. Plante Moran Advisors Limited Company holds 1.28% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 16,542 shares. 18,299 were reported by United Commercial Bank. Palladium Prns holds 170,544 shares or 1.69% of its portfolio. Jarislowsky Fraser Limited reported 1.60 million shares. Pennsylvania-based Peoples Finance has invested 1.98% in Johnson & Johnson (NYSE:JNJ). Horizon Investments has invested 0.13% in Johnson & Johnson (NYSE:JNJ). Strs Ohio reported 0.97% in Johnson & Johnson (NYSE:JNJ). Seabridge Advsr Ltd Com invested in 125 shares or 0% of the stock. Credit Suisse Ag holds 0.58% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 4.61M shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.